| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 621,070 | 632,252 | 596,411 | 695,833 | | Cost of Revenue | (1,266,452) | 422,300 | 406,588 | 437,564 | | | Gross Profit | 1,887,522 | 209,952 | 189,823 | 258,269 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,006,421 | 96,019 | 101,874 | 104,851 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| 29,790 | 74,979 | 24,870 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,740 | 84,143 | 12,970 | 128,548 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 72,748 | 79,762 | 19,662 | 133,555 | | Interest Expense | 10,865 | 7,453 | 6,744 | 31,891 | | Income Before Tax | 61,883 | 72,309 | 12,918 | 101,664 | | Income Tax Expense | 18,914 | 29,714 | 6,825 | 40,571 | | Minority Interest | 5,055 | (4,381) | 6,692 | 5,007 | | | | Net Income From Continuing Ops | 55,342 | 42,595 | 6,093 | 61,093 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,969 | 42,595 | 6,093 | 61,093 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $42,969 | $42,595 | $6,093 | $61,093 |
|
0.20% Nasdaq 
Income Statement
